(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Lecturer who called Israel a terrorist state to remain Plaid Cymru candidate - 2Blue Origin's next space tourism flight will break new ground for people with disabilities
- 3The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- 4Born under fire: MDA delivers baby in Jerusalem minutes before rushing to shelter
- 5A definitive Bike Standoff: Decision in favor of Your Number one Ride
- Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- Figure out How to Keep up with and Clean Your Brilliant Bed for Ideal Execution
- A Manual for Pick Dependable Vehicle Rental Administrations For 2024
- Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- 10 Setting up camp Shelters That Offer Both Excellence and Isolation
- The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- Blue Origin launches huge rocket carrying twin NASA spacecraft to Mars
- The most effective method to Offset Album Rates with Liquidity Needs
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
